Illumina, Inc. - Common Stock (ILMN)
Healthcare › Laboratory Analytical Instruments
Price History
Feb 9, 2026 — Mar 29, 2026Investment Snapshot
- Trading 174% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- Strong ROE of 25.8% with 16.5% net margin
Illumina, Inc. - Common Stock (ILMN) is a Healthcare company operating in Laboratory Analytical Instruments, listed on the NASDAQ , with a market capitalisation of $18.0 billion . Key value metrics: P/E ratio 25.6, P/B ratio 6.61, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Illumina, Inc. - Common Stock — Fundamental Analysis Summary
Illumina, Inc. - Common Stock (ILMN) is currently trading 174% above its Graham Number of $42.89, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 25.6x.
On financial health, ILMN shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and strong return on equity of 25.8% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.00.
StockPik's composite Value Score for ILMN is 81/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ILMN reports a high gross margin of 67.0% (sector average: 33.5%) and a strong operating margin of 31.6%.
ILMN shows revenue declining at 1% year-over-year, with earnings growing at 170%.